Aug 2026· IEEE journal of biomedical and health informatics· Vol PP, pp. 1-17· 0 citations
Medicine
TL;DR
This study confirms the pivotal role of anatomical priors, offering a novel paradigm for balancing attack imperceptibility with efficiency and pro viding a low-resource framework for evaluating medical AI robustness.
Abstract
Prostate cancer is a highly prevalent malignancy, and deep learning has significantly advanced di agnostic models based on multi-parametric MRI (mpMRI). However, the robustness of these models is threatened by adversarial attacks, potentially leading to fatal misdiagnoses and impeding clinical translation. Unlike natural images, the vulnerability of medical images lies within anatomical details and multi-modal variations, creating an "efficiency-imperceptibility" dilemma for existing black-box attacks. Low-precision strategies (e.g., Square Attack, sign Hunter) lack fine-grained anatomical awareness, introducing redundancy in non-critical areas, while high-precision strategies (e.g., NES, ZOO) suffer from prohibitive query costs due to vast search spaces. To address this, we pro pose an Anatomical Prior-Guided black-box optimization method. By integrating mpMRI Regions of Interest (ROI) with model sensitivity analysis via local finite difference probing, we construct a dynamic weight map to quantify decision responses. This constrains the optimization to diagnostically critical high-frequency regions, specifically enhancing high-precision strategies to generate minute yet disruptive perturbations. Experiments on multiple prostate mpMRI datasets demonstrate that our method reduces query overhead by 40%-70% and pixel modification count (L0 norm) by over 40%. This study confirms the pivotal role of anatomical priors, offering a novel paradigm for balancing attack imperceptibility with efficiency and pro viding a low-resource framework for evaluating medical AI robustness. The project code will be made publicly available upon acceptance.
The robustness analysis reveals a trade-off: MedSAM tolerates prompt perturbations, while Medical SAM 2 achieves higher accuracy but degrades under box tightening and spatial shifts, supporting the use of SAM-based models for multi-cancer segmentation, while showing that reliability depends on prompt quality and anatom...
M. Tortora, Elena Mulero Ayllón, Filippo Ruffini et al.· Scientific Reports· 0 citations
PURPOSE
Despite remarkable auto-segmentation performance and growing clinical adoption, models frequently fail to generalize beyond the training distribution. Therefore, this study aimed to develop and validate an uncertainty-aware segmentation pipeline that yields high delineation accuracy for liver cancer patients an...
D. Langner, C. Gani, S. Boeke et al.· Radiotherapy and Oncology· 0 citations
Objective. Accurate Ultrasound (US) prostate cancer (PCa) segmentation images hold significant value for organ interventional guidance and clinical disease diagnosis. However, this task still poses substantial challenges. The main obstacles include blurred or incomplete boundaries separating PCa from adjacent soft tiss...
Yu Wang, Li-Li Wang, Cai-Shan Wang et al.· Physics in Medicine and Biol...· 0 citations
This study provides a clear and actionable framework to bridge the gap between DL‐based segmentation research and clinical deployment, and proposes a roadmap for future research focusing on lightweight architectures, edge–cloud integration, federated learning and explainable AI (XAI).
Muhammad Sufyan, Jun Qian, Jianqiang Li et al.· Expert systems· 0 citations
The proposed model surpasses current methods and shows potential for practical clinical applications, providing an efficient, precise, and scalable solution for automated prostate cancer segmentation and fostering optimism for the future of medical imaging and diagnosis.
The proposed framework substantially outperforms finetuned radiology foundation models and prior methods, improving mean AUROC by nearly 8 points and balanced accuracy by 4 points over the strongest baseline, further demonstrating its effectiveness for robust breast cancer classification.
Benjamin Hamm, Y. Kirchhoff, M. Rokuss et al.· International Conference on...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.